Bio-Rad Laboratories (BIO-B) Shares Outstanding (Weighted Average) (2009 - 2026)

Bio-Rad Laboratories (BIO-B) has 18 years of Shares Outstanding (Weighted Average) data on file, last reported at $27.0 million in Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $27.0 million, down 3.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $27.0 million (down 3.52% YoY), and the FY2025 annual result was $27.3 million, down 3.37% from the prior year.
• Shares Outstanding (Weighted Average) slipped to $27.0 million in Q1 2026 per BIO-B's latest filing, from $27.3 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $29.9 million in Q1 2022 and troughed at $26.9 million in Q3 2025.
• A 5-year average of $28.6 million and a median of $28.5 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Weighted Average) climbed 0.37% in 2022, then decreased 4.82% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $29.8 million in 2022, then retreated by 1.93% to $29.2 million in 2023, then retreated by 3.41% to $28.2 million in 2024, then declined by 3.37% to $27.3 million in 2025, then declined by 1.12% to $27.0 million in 2026.
• Business Quant data shows BIO-B's Shares Outstanding (Weighted Average) at $27.0 million in Q1 2026, $27.3 million in Q4 2025, and $26.9 million in Q3 2025.